June 1, 2023
PHRI at ESO 2023
PHRI was well-represented at the European Stroke Organisation (ESO) 2023 conference in Munich, Germany May 24-26. PHRI Scientists Mike Sharma, Ashkan...
Read More
May 31, 2023
Next-generation proteomics
PHRI is well positioned to access the latest advances in proteomics. One of our senior scientists, Guillaume Paré, runs the...
Read More
May 22, 2023
HF 2023: Three-year outcomes of PACT-HF
Yesterday at the Heart Failure Association (HFA)’s Heart Failure 2023 Late-Breaking Clinical Trials: Patient Monitoring session, PHRI Scientist Harriette Van...
Read More
May 19, 2023
7 times more risk of tricuspid regurgitation with TV-ICD vs. S-ICD
Transvenous defibrillators (TV-ICDs), implanted in a patient’s heart, may cause or significantly worsen the risk of tricuspid regurgitation (TR) –...
Read More
May 18, 2023
Clinical Trials Day
It’s International Clinical Trials Day this Saturday; you could say every day is Clinical Trials Day this year in Canada,...
Read More
May 16, 2023
Heart failure deadly and under-treated in most countries: global study of 40 countries
The common condition of heart failure (HF) is deadly and undertreated in most countries, including high-income countries such as Canada;...
Read More